Effect of magnesium supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

Current Pharmaceutical Design

Volumn 23, Issue 31, 2017, Pages 4678-4686

  Simental Mendía, Luis E ^a   Sahebkar, Amirhossein ^b,c   Rodríguez Morán, Martha ^a   Zambrano Galván, Graciela ^d   Guerrero Romero, Fernando ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

C reactive protein; Inflammation; Magnesium; Meta analysis; Plasma concentrations; Randomized controlled trials

Indexed keywords

C REACTIVE PROTEIN; MAGNESIUM;

CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; FOOD COMPOSITION; HUMAN; INFLAMMATION; MAGNESIUM INTAKE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW; BLOOD; DIETARY SUPPLEMENT; METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC);

C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; MAGNESIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85040341416     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612823666170525153605     Document Type: Review

References (59)

1. Lopez Martinez J, Sanchez Castilla M, Garcia de Lorenzo y Mateos A, Culebras Fernandez JM. Magnesium: Metabolism and requirements. Nutr Hosp 1997; 12: 4
2. Paolisso G, Scheen A, D'Onofrio F, Lefèbvre P. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-4.
3. Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther 2007; 14(4): 375-85.
4. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: The role of intracellular magnesium. Am J Hypertens 1997; 10: 346-55.
5. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium 1985; 4(5-6): 245-71.
6. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr 2007; 26(2): 121-32.
7. Santos DA, Matias CN, Monteiro CP, et al. Magnesium intake is associated with strength performance in elite basketball, handball and volleyball players. Magnes Res 2011; 24(4): 215-9.
8. Dominguez LJ, Barbagallo M, Lauretani F, et al. Magnesium and muscle performance in older persons: The InCHIANTI study. Am J Clin Nutr 2006; 84(2): 419-26.
9. Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mgdeficient rat. Magnes Res 2003; 16(2): 91-7.
10. Scholzen TE, Steinhoff M, Bonaccorsi P, et al. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol 2001; 166(2): 1285-91.
11. Weglicki WB, Chmielinska JJ, Tejero-Taldo I, et al. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 2009; 22(3): 167S-173S.
12. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res 1994; 74(5): 1009-13.
13. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation and metabolic syndrome. Diabetes Metab Res Rev 2006; 22(6): 471-6.
14. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch Biochem Biophys 2007; 458(1): 48-56.
15. King DE. Inflammation and elevation of C-reactive protein: Does magnesium play a key role? Magnes Res 2009; 22(2): 57-9.
16. Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26(4): 469-74.
17. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85(4): 1068-74.
18. Almoznino-Sarafian D, Berman S, Mor A, et al. Magnesium and Creactive protein in heart failure: An anti-inflammatory effect of magnesium administration? Eur J Nutr 2007; 46(4): 230-7.
19. Chacko SA, Sul J, Song Y, et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: A randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011; 93(2): 463-73.
20. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: A clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45(4): 325-30.
21. Simental-Mendía LE, Rodríguez-Morán M, Reyes-Romero MA, Guerrero-Romero F. No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: A pilot study. Magnes Res 2012; 25(3): 140-6.
22. Moslehi N, Vafa M, Rahimi-Foroushani A, Golestan B. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J Res Med Sci 2012; 17(7): 607-14.
23. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27(3): 813-23.
24. Mirhafez SR, Ebrahimi M, Saberi Karimian M, et al. Serum highsensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: Evidence-based study with 7284 subjects. Eur J Clin Nutr 2016.
25. Weglicki WB. Hypomagnesemia-related inflammation in heart disease and diabetes. Cir Cir 201280(3): 209-10.
26. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: B2535.
27. Higgins JPT, Green S eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. London: The Cochrane Collaboration 2009.
28. Broncel M, Gorzelak-Pabiś P, Sahebkar A, et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Sleep changes following statin therapy: A systematic review and metaanalysis of randomized placebo-controlled polysomnographic trials. Arch Med Sci 2015; 11(5): 915-26.
29. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis version 2. Englewood, NJ: Biostat 2005.
30. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
31. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research, West Sussex: John Wiley & Sons; 2000.
32. Sahebkar A, Soranna D, Liu X, et al. A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure. J Hypertens 2016; 34(11): 2127-35.
33. Ferretti G, Bacchetti T, Sahebkar A. Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res 2015; 60: 50-73.
34. Sahebkar A. Are curcuminoids effective C-reactive proteinlowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014; 28: 633-42.
35. Sahebkar A, Simental-Mendía LE, Stefanutti C, Pirro M. Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis. Pharmacol Res 2016; 105: 198-209.
36. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 2000; 56: 455-63.
37. Kazaks AG, Uriu-Adams JY, Albertson TE, Shenoy SF, Stern JS. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: A randomized placebo controlled trial. J Asthma 2010; 47(1): 83-92.
38. Asemi Z, Karamali M, Jamilian M, et al. Magnesium supplementation affects metabolic status and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2015; 102(1): 222-9.
39. Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: A double-blind, randomized, placebo-controlled trial. Eur Neurol 2013; 69(5): 309-16.
40. Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnes Res 2010; 23(2): 90-6.
41. Cosaro E, Bonafini S, Montagnana M, et al. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr Metab Cardiovasc Dis 2014; 24: 1213-20
42. Lima de Souza E Silva Mde L, Cruz T, Rodrigues LE, et al. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: A 12-week randomized double-blind study. J Clin Med Res 2014; 6: 456-62.
43. Mak IT, Kramer JH, Chmielinska JJ, Khalid MH, Landgraf KM, Weglicki WB. Inhibition of neutral endopeptidase potentiates neutrophil activation during Mg-deficiency in the rat. Inflamm Res 2008; 57(7): 300-5.
44. Malpuech-Brugère C, Nowacki W, Daveau M, et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000; 1501(2-3): 91-8.
45. Kisters K, Spieker C, Tepel M, Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993; 6(4): 355-60.
46. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 2015; 10: 1257-72.
47. Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 2016; 111: 272-82.
48. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15(2), 74-80.
49. Choi YS, Hur J, Jeong S. β-Catenin binds to the downstream region and regulates the expression C-reactive protein gene. Nucleic Acids Res 2007; 35(16): 5511-19.
50. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989; 8(12): 3773.
51. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formation. Blood 2003; 101(2): 545-51.
52. Baeuerle PA. The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072(1): 63-80.
53. Baldwin Jr. AS. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996; 14(1): 649-81.
54. Ali S, Mann DA. Signal transduction via the NF-kappaB pathway: A targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 2004; 22(2): 67-79.
55. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005; 7(3-4): 395-403.
56. Altura BM, Gebrewold A, Zhang A, Altura BT. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: Possible relation to traumatic brain injury and strokes. Neurosci Lett 2003; 341(3): 189-92.
57. Ford ES, Mokdad AH. Dietary Magnesium Intake in a National Sample of U.S. Adults. J Nutr 2003; 133: 2879-82
58. Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity Creactive protein and cardiovascular disease: A resolute belief or an elusive link? J Am Coll Cardiol 2013; 62(5): 397-408.
59. Goff DC Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63(25 Pt B): 2935-59.